← Back to Search

Diagnostic Monitoring Techniques for Light Sensitivity

N/A

Recruiting

Research Sponsored by Randy Kardon

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18-80

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 day

Awards & highlights

Study Summary

This trial will test a new way of diagnosing and treating light sensitivity and headache by measuring a person's facial features, pupil responses, retinal electrical responses, and autonomic nerve responses to light.

Who is the study for?

This trial is for healthy individuals aged 18-80 who have had a normal eye exam in the past year. It's designed to help those with traumatic brain injury and associated light sensitivity or migraines by objectively measuring their response to light.Check my eligibility

What is being tested?

The study tests new methods like videography, ocular coherence tomography (OCT), wrist-watch sensor devices, pupillography, and electrophysiology to diagnose and monitor treatment of light sensitivity and headaches in patients.See study design

What are the potential side effects?

Since this trial involves diagnostic tools rather than medications, traditional side effects are not expected. However, participants may experience discomfort from bright lights or wearing sensors.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 80 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 day

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 day

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Correlation of facial responses to light sensitivity

Difference in objective biological markers of light sensitivity between light sensitive and normal subjects

Secondary outcome measures

Correlation of objective biological marker of light sensitivity to macula (structure found in the back of the eye).

Correlation of objective biological marker of light sensitivity to optic nerve structures

Trial Design

5Treatment groups

Active Control

Group I: TBI patients with photosensitivityActive Control5 Interventions

Group II: Migraine patients without photosensitivityActive Control5 Interventions

Group III: Migraine patients with photosensitivityActive Control5 Interventions

Group IV: TBI Patients without photosensitivityActive Control5 Interventions

Group V: Healthy Control subjectsActive Control5 Interventions

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Randy KardonLead Sponsor

3 Previous Clinical Trials

1,001 Total Patients Enrolled

Media Library

TBI patients with photosensitivity Clinical Trial Eligibility Overview. Trial Name: NCT03694626 — N/A

Light Sensitivity Research Study Groups: TBI patients with photosensitivity, Migraine patients without photosensitivity, Migraine patients with photosensitivity, TBI Patients without photosensitivity, Healthy Control subjects

Light Sensitivity Clinical Trial 2023: TBI patients with photosensitivity Highlights & Side Effects. Trial Name: NCT03694626 — N/A

TBI patients with photosensitivity 2023 Treatment Timeline for Medical Study. Trial Name: NCT03694626 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research initiative actively accepting new participants?

"Clinicaltrials.gov affirms that this medical trial is actively recruiting participants and was first posted on July 11th 2019, with the most recent update occurring in July 2022."

Answered by AI

Who is eligible to join in this clinical research project?

"To be eligible for this clinical experiment, patients must suffer from photophobia and should fall between the ages of 18 to 80. The total number of participants they are seeking is 120 individuals."

Answered by AI

Are geriatric patients excluded from eligibility for this trial?

"This study only admits patients aged between 18 and 80. Those below the age of majority can apply to one of the 80 other trials, while those over 65 have a choice from 303 different studies."

Answered by AI

How many individuals have enrolled in the clinical trial thus far?

"Affirmative. Clinicaltrials.gov reveals that the clinical trial was published on July 11th 2019 and has since been updated to include new information as of July 4th 2022, with a goal of recruiting 120 patients from 1 medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Objectively Diagnose and Monitor Treatment of Light Sensitivity

Randy Kardon 2019. "Objectively Diagnose and Monitor Treatment of Light Sensitivity". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03694626.